Mathieu Le Gars

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 19 papers. Top paper: “Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S”.

Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S

New England Journal of Medicine(2022)10.1056/nejmoa2117608

N/A

4.6DataRank · unranked

251 citations

Glenda Gray, An Vandebosch, Vicky Cárdenas, Georgi Shukarev, Beatriz Grinsztejn +24 more

Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial

Nature Microbiology(2022)10.1038/s41564-022-01262-1

N/A

2.6DataRank · unranked

93 citations

Adrian B. McDermott, David Benkeser, Sanne Roels, Daniel J Stieh, An Vandebosch +56 more

Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial

The Lancet Infectious Diseases(2022)10.1016/s1473-3099(22)00506-0

N/A

2.0DataRank · unranked

89 citations

An Vandebosch, Jerald Sadoff, Mathieu Le Gars, Carla Truyers, D. Lowson +95 more

Safety, reactogenicity, and immunogenicity of Ad26.COV2.S co-administered with a quadrivalent standard-dose or high-dose seasonal influenza vaccine: a non-inferiority randomised controlled trial

EClinicalMedicine(2025)10.1016/j.eclinm.2024.103016

N/A

0.249DataRank · unranked

4 citations

Gloria Aguilar, Nathalie Vaissière, Carla Truyers, Pedro Ylisastigui, Erik Buntinx +15 more

Durable Humoral and Cellular Immune Responses Following Ad26.COV2.S Vaccination for COVID-19

medRxiv(2021)10.1101/2021.07.05.21259918

N/A

0DataRank · unranked

21 citations

Kathryn E. Stephenson, Jerald Sadoff, Jingyou Yu, Aiquan Chang, Makda S. Gebre +12 more

Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans

UNC Libraries(2021)10.17615/phnx-3j92

N/A

0DataRank · unranked

0 citations

Kathryn E. Stephenson, Jingyou Yu, Aiquan Chang, Johan Van Hoof, Sally Shin +26 more

Immunogenicity and efficacy of Ad26.COV2.S: An adenoviral vector–based COVID‐19 vaccine

Immunological Reviews(2022)10.1111/imr.13088

N/A

0DataRank · unranked

27 citations

Jenny Hendriks, Jerald Sadoff, Martin Ryser, Frank Struyf, Macaya Douoguih +2 more

Quantifying Antibody Persistence After a Single Dose of COVID‐19 Vaccine Ad26.COV2.S in Humans Using a Mechanistic Modeling and Simulation Approach

Clinical Pharmacology & Therapeutics(2022)10.1002/cpt.2796

N/A

0DataRank · unranked

8 citations

Muriel Boulton, Martine Neyens, Mathieu Le Gars, Belén Valenzuela, Georgi Shukarev +6 more

Passive transfer of Ad26.COV2.S-elicited IgG from humans attenuates SARS-CoV-2 disease in hamsters

npj Vaccines(2022)10.1038/s41541-021-00427-z

N/A

0DataRank · unranked

2 citations

Abishek Chandrashekar, Shivani Patel, Jingyou Yu, Catherine Jacob-Dolan, Aiquan Chang +30 more

Immune Correlates Analysis of a Single Ad26.COV2.S Dose in the ENSEMBLE COVID-19 Vaccine Efficacy Clinical Trial

medRxiv(2022)10.1101/2022.04.06.22272763

N/A

0DataRank · unranked

12 citations

Adrian B. McDermott, David Benkeser, Sanne Roels, Daniel J Stieh, An Vandebosch +56 more

Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features

Research Square(2023)10.21203/rs.3.rs-2743022/v1

N/A

0DataRank · unranked

0 citations

Li Li, Allan C. deCamp, Morgane Rolland, Michal Juraska, Brian D. Williamson +38 more

Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features

Nature Communications(2024)10.1038/s41467-024-46536-w

N/A

0DataRank · unranked

12 citations

Li Li, Allan C. deCamp, Morgane Rolland, Michal Juraska, Brian D. Williamson +45 more

B cell somatic hypermutation following COVID-19 vaccination with Ad26.COV2.S

iScience(2024)10.1016/j.isci.2024.109716

N/A

0DataRank · unranked

4 citations

Michelle A. Lifton, Olivia Powers, Jessica Miller, Nicole P. Hachmann, Mya Vu +11 more

Ad26.COV2.S COVID-19 Vaccine Safety And Immunogenicity in Adolescents 16–17 Years of Age

Journal of the Pediatric Infectious Diseases Society(2024)10.1093/jpids/piae098

N/A

0DataRank · unranked

0 citations

Mathieu Le Gars, Vicky Cárdenas, Nathalie Vaissière, Jerald Sadoff, Carla Truyers +7 more

CytoGLMM: Conditional Differential Analysis for Flow and Mass Cytometry Experiments

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.12.09.417584

N/A

0DataRank · unranked

2 citations

Anne-Maud Ferreira, Lisa M. Kronstad, Laura J. Simpson, Mathieu Le Gars, Elena Vendrame +3 more

Immune correlates analysis of antibody responses against SARS-CoV-2 variants in the ENSEMBLE vaccine efficacy trial

iScience(2025)10.1016/j.isci.2025.113660

N/A

0DataRank · unranked

1 citations

Youyi Fong, Lars van der Laan, Fei Heng, Ying Huang, Yiwen Lu +61 more

Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans

Nature(2021)10.1038/s41586-021-03681-2

N/A

0DataRank · unranked

352 citations

Jingyou Yu, Jinyan Liu, Abishek Chandrashekar, Erica N. Borducchi, Lisa H. Tostanoski +26 more

CytoGLMM: conditional differential analysis for flow and mass cytometry experiments

BMC Bioinformatics(2021)10.1186/s12859-021-04067-x

N/A

0DataRank · unranked

37 citations

Anne-Maud Ferreira, Lisa M. Kronstad, Laura J. Simpson, Mathieu Le Gars, Elena Vendrame +3 more

Durability of antibody responses elicited by a single dose of Ad26.COV2.S and substantial increase following late boosting

medRxiv(2021)10.1101/2021.08.25.21262569

N/A

0DataRank · unranked

23 citations

Mathieu Le Gars, Vicky Cárdenas, Georgi Shukarev, Nathalie Vaissière, Dirk Heerwegh +10 more